Crisis hipertensiva por punción biopsia de feocromocitoma adrenal: a propósito de un caso.

Carlos E. Bauni, Mónica E. Mendoza, Daniel A. Vives, Silvana Pravato

Resumen


Se presenta el caso de un paciente adulto masculino que sufrió una crisis hipertensiva por la punción de un incidentaloma suprarrenal. Era portador de una neoplasia endócrina múltiple tipo 2A (NEM 2A). Se describe la utilidad del diagnóstico para descartar un feocromocitoma en el momento de decidir una práctica invasiva como la biopsia. Se analiza el dosaje de metabolitos de las catecolaminas [normetanefrina (NMN), metanefrina (MN) y ácido vainillín mandélico (AVM)] como método diagnóstico de certeza. Se plantea la ventaja del tratamiento preventivo para evitar la crisis hipertensiva descripta en este paciente.


Palabras clave


feocromocitoma; incidentaloma adrenal; biopsia; crisis hipertensiva

Texto completo:

11-14

Referencias


Mantero F,Masini AM, Opocher G et al. Adrenal incidentaloma: an overview of hormonal data from the National Italian Study Group. Horm Res 1997; 47:284-9.

Kasperlik-Zaluska AA, Rotonowska E, Slowinska-Srzednicka J et al. Incidentally discovered adrenal mass (incidentaloma): investigation and management of 208 patients. Clin Endocrinol 1997; 46:26-37.

Bondanelli M, Campo M, Trasforini G et al. Evaluation of hormonal function in a series of incidentally discovered adrenal masses. Metabolism 1997; 46: 107-13.

Kawashima A, Sandler C M, Fishman E K et al. Spectrum of CT findings in nonmalignant disease of the adrenal gland. Radiographics 1998; 18:393-412.

McCorkell SJ, Niles N L. Fine-needle aspiration of catecholamine-producing adrenal masses: a possibly fatal mistake. AJR 1985; 145: 113-114.

Casola G, Nicolet V: vanSonnenberg E et al. Unsuspected pheochromocytoma: risk of blood-pressure alteracions during percutaneous adrenal biopsy. Radiology 1986; 159:733-735.

Stein PP, Black HR. A simplified diagnostic approach to pheocromocitoma. A review of the literature and report of one institution´s experience. Medicine (Baltimore) 1991; 70:46-66.

Neumann HP, Berger DP, Sigmund G et al. Pheochromocytoma, multiple endocrine type 2, and von Hippel Lindau disease. N Engl J Med 1993; 329:1531-8.

Bravo EL. Pheochromocytoma: New concepts and future trends. Kidney Int 1991; 40:544-56.

Bravo EL. Evolving concepts in the pathophysiology, diagnosis and treatment of pheochromocytoma. Endocr Rev 1994; 15:356-68.

Gagel RF, Tashjian AH, Cummings T et al. The clinical outcome of prospective screening for multiple endorine neoplasia type 2 a. An 18-year experience . N Engl J Med 1988; 318:478-84.

Wocial B, Januszewicz W, Glryglas P, Januszewicz A, Feltynowski T, Lapinski M. Evaluation of the usefulness for measuring catecholamines and their principle metabolites in the diagnosis of pheocromocytoma. Przegl Lek 1997; 54:793-8.

Ito Y, Obara T, Okamoto T et al. Efficacy of single-voided urine metanephrine and normetanephrine assay for diagnosing pheocromocytoma. World J Surg 1998; 22:684-8.

Belldegrun A, Hussain S, Seltzer ES et al. Incidentally discovered mass of the adrenal gland. Surg Gynecol Obstet 1986; 163:203-8.

Grossman E, Goldstein DS, Hoffman A, Keiser HR. Glugagon and clonidine testing in the diagnosis of pheochromocytoma. Hypertension 1991; 17:733-41.


Enlaces refback

  • No hay ningún enlace refback.


Copyright (c) 2019 Carlos E. Bauni, Mónica E. Mendoza, Daniel A. Vives, Silvana Pravato



Asociación Médica de Bahía Blanca - Castelli 213 - B8000AIE Bahía Blanca - Buenos Aires - Argentina - https://www.ambb.org.ar